Granules India to acquire Senn Chemicals to expand CDMO business
Granules India Limited (BSE: 532482, NSE: GRANULES) has announced a strategic acquisition of Senn Chemicals AG, a Switzerland-based Contract Development and Manufacturing Organization (CDMO) specializing ... Read More
FDA approves first generic liraglutide injection for Type 2 diabetes treatment
In a significant milestone for diabetes care, the U.S. Food and Drug Administration (FDA) has approved the first generic equivalent of liraglutide injection, a glucagon-like ... Read More